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Summary 
The glycosaminoglycan (GAG) molecules are a group of high 
molecular weight, negatively charged polysaccharides present 
abundantly in the mammalian organism. By their virtue of ion 
and water binding capacity, they may affect the redistribution of 
body fluids and ultimately the blood pressure. Data from the 
literature suggests that the mitogens Vascular Endothelial Growth 
Factor (VEGF)-A and VEGF-C are able to regulate the amount and 
charge density of GAGs and their detachment from the cell 
surface. Based on these findings we investigated the relationship 
between the level of dietary sodium intake, the expression levels 
of VEGF-A and VEGF-C, and the amount of the skin GAGs 
hyaluronic acid and chondroitin sulfate in an in vivo rat model. 
Significant correlation between dietary sodium intake, skin 
sodium levels and GAG content was found. We confirmed the 
GAG synthesizing role of VEGF-C but failed to prove that GAGs 
are degraded by VEGF-A. No significant difference in blood 
pressure was registered between the different dietary groups. 
A quotient calculated form the ion and water content of the skin 
tissue samples suggests that – in contrast to previous findings – 
the osmotically inactive ions and bound water fractions are 
proportional. 
Key words 
Glycosaminoglycans • Sodium • Body fluids • Blood pressure • 
Vascular Endothelial Growth Factor 
Corresponding author 
A. J. Szabó, First Department of Pediatrics, Semmelweis 
University, 1083 Budapest, Bókay János u. 53-54., 
Budapest, Hungary. Fax: +36-1-3036077. E-mail: 
attila.szabo@med.semmelweis.univ.hu 
Introduction 
Recent experimental data have suggested that in 
addition to the kidney local tissue regulation of sodium 
and volume by the skeletal muscle, the bone and the skin 
is of great importance as these tissues are able to store 
and release significant amounts of sodium. A number of 
previous studies (Heer et al. 2000, Palacios et al. 2004, 
Titze et al. 2002a) reported on the short term changes in 
volume of body fluid compartments following 
Na+ ingestion: increment in total body mass as well as 
body fluid content were observed. 
Heer et al. (2000) were the first to demonstrate 
that the rise in total body sodium content is not 
necessarily paralleled by commensurate water retention. 
The same conclusion was drawn by other research groups 
(Palacios et al. 2004, Titze et al. 2002b) It has also been 
proved that the excretion of sodium through urine, stool 
and sweat does not match the amount of the ingested 
sodium, suggesting a water free storage of the excess 
sodium (Heer et al. 2000, Palacios et al. 2004). Seeliger 
and his colleagues (Seeliger et al. 2006) criticized these 
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results, stating that water-free sodium storage is more 
likely to be an intracellular mechanism. Data from further 
examinations (Heer et al. 2009, Schafflhuber et al. 2007) 
have shown that the mechanism in question accounts only 
for the 22 % of Na+ to remain in the body. The rest 
(78 %) is presumably stored in an osmotically inactive 
manner in the EC compartment. 
Based on these experimental data and clinical 
observations it became evident that there is not a close 
link between the total sodium content of the body and the 
volume of different water compartments in the long term. 
Given that the above mentioned intracellular Na+/K+ 
exchange only partially accounts for the storage of excess 
sodium and that the sodium concentration of the serum 
remained in the normal physiological range during salt 
overload, it is presumable that considerable sodium 
reservoirs exist in the mammalian organism. Animal 
experiments conducted on salt sensitive and salt resistant 
rat strains supported the sodium buffering role of the 
hypothesized sodium reservoirs (Titze et al. 2002a). 
Further animal experiments (Titze et al. 2002a, Titze et 
al. 2003) determined the location of these osmotically 
inactive reservoirs: the majority of the excess sodium is 
stored in the skin, and only a smaller fraction is located in 
the bone, the cartilage and the skeletal muscle (Sulyok 
2006) The presence of osmotically inactive sodium 
storages have also been confirmed applying 23Na and 1H 
MR techniques in humans in vivo (Dahlmann et al. 2015, 
Kopp et al. 2013, Kopp et al. 2012, Linz et al. 2015). 
Sodium in the skin is bound to negatively charged 
macromolecules, predominantly to glycosaminoglycans 
(GAGs). GAGs are nitrogen containing molecules made up 
of repeated dimers. The most common GAGs of the body 
are hyaluronic acid, heparin sulfate, chondroitin sulfate and 
dermatan sulfate. It has also been shown that the total 
content, charge density and polymerization of GAGs 
correlates with the extremes in dietary sodium intake 
(Farber et al. 1957, Machnik et al. 2009, Titze et al. 2004). 
Titze et al. (2009) proposed a regulating cascade in which 
increased subcutaneous sodium modulates lymphan-
giogenesis and blood pressure (Machnik et al. 2009). 
Macrophages accumulating in the subcutaneous 
compartment sense hypertonicity and facilitate lymph 
capillary hyperplasia via Vascular Endothelial Growth 
Factor-C (VEGF-C) secretion. Increased lymph capillaries 
temporarily store the interstitial fluid and blunt blood 
pressure response to high salt. 
This concept does not provide information about 
the mechanism by which this uniquely bound sodium is 
released and drained back to the circulation. (Foster et al. 
2013) provided evidences that two isoforms of Vascular 
Endothelial Growth Factor, VEGF-A and VEGF-C 
regulate the amount and charge density of the glycocalyx 
of conditionally immortalized glomerular endothelial 
cells of the kidney podocytes. Based on these results, we 
attempted to define the role of skin GAGs in the 
regulation of body sodium homeostasis. We wanted to 
investigate, whether this regulated synthesis and 
degradation of GAG molecules is also present in the skin, 
and whether this phenomenon plays significant role in the 
regulation of skin sodium levels. 
 
Methods 
 
Animals 
8-week-old female Wistar rats (weight  
180-200 g) were purchased from Toxi-Coop Ltd. 
(Dunakeszi, Hungary). All experimental protocols were 
approved by the Committee on the Care and Use of 
Laboratory Animals of the Council on Animal Care at the 
Semmelweis University of Budapest, Hungary (TUKEB 
380/2013). 
 
Treatment groups 
In all experiments two types of dietary regimes 
were applied: low salt diet (LSD) consisted of a virtually 
sodium free (NaCl<0.03 % m/m) rat chow (E 15430-24; 
Ssniff Gmbh, Soest, Germany) and tap water to drink. 
High salt diet (HSD) consisted of a sodium rich 
(NaCl=8 % m/m) rat chow and 0.9 % saline as drinking 
water (treatment groups are summarized in Table 1). 
In Experiment 1, 24 rats after one week of 
standard diet were randomly assigned to three groups. 
Group LSD (n=8) received a low salt diet for 4 weeks. 
Group HSD (n=8) received a high salt diet for 4 weeks. 
Group HSD/LSD (n=8) received a high salt diet for 
4 weeks followed by a low salt diet for another 4 weeks. 
In Experiment 2, 24 female Wistar rats after one 
week of standard diet were randomly assigned to two 
groups. Group LSD (n=12) received a low salt diet for 
4 weeks. Group HSD (n=12) received a high salt diet for 
4 weeks. 
In Experiment 3, 12 female Wistar rats after one 
week of standard diet were kept on a high salt diet for 
four weeks followed by a 72 h period of low salt diet. The 
animals were kept under standard laboratory conditions 
with free access to the respective rodent chow and 
drinking water. 
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Table 1. Description of treatment groups. 
 
 Experiment 1 Experiment 2 Experiment 3 
Species/Strain Rattus norvegicus/Wistar 
Gender/Age Female/8-week old 
Treatment groups LSD HSD HSD/LSD LSD HSD HSD/LSD 
Sample size (n) 8 8 8 12 12 12 
Time span of the 
experiment 
After 1 week of standard diet 
4 weeks 4 weeks 4 + 4 weeks 4 weeks 4 weeks 4 weeks + 72 h 
 
Abbreviations: LSD – low salt diet, HSD – high salt diet, HSD/LSD – high salt diet followed by low salt diet. 
 
 
Body weight measurement 
Body weight of the animals was measured every 
week during the whole experimental period. 
 
Blood pressure measurement 
In Experiments 2 and 3 arterial blood pressure 
(systolic, diastolic, mean (MAP)) was measured with 
Coda (Kent Scientific Corporation, Torrington, USA) 
non-invasive digital blood pressure monitor. Blood 
pressure was measured on the tail arteries of conscious 
animals. Measurements were performed once every week 
during the whole experimental period. 
 
Blood, urine and skin sampling 
At the end of the experiments the animals were 
anesthetized using intraperitoneal Ketamine-Xylazine 
injection, and blood samples (5 ml) were taken from the 
right cardiac ventricle before the animals were killed. We 
obtained urine samples by bladder puncture. The 
carcasses were skinned to provide tissue samples for 
biochemical and chemical analyses and for the 
determination of gene expression levels. 
 
Determination of ions, creatinine and urea in serum and 
urine 
The Na+, K+, Cl-, creatinine and urea content of 
the blood and the urine samples was analysed with  
a Beckman Coulter AU480 Chemistry System. 
 
Determination of skin water content 
In Experiment 2 the skin samples were weighed 
(wet weight) and then desiccated at 90 °C for 72 h (dry 
weight). Because further drying left weights unchanged, 
the difference between wet weight and dry weight was 
considered as tissue water content. 
 
 
Determination of skin Na+ and K+ content 
In Experiment 1 and Experiment 2 skin samples 
were frozen by liquid nitrogen and pulverized 
mechanically with a commercially available coffee grinder. 
Thereafter 1 gram of the raw (Experiment 1) or the 
desiccated (Experiment 2) skin samples were dissolved in 
5 ml HNO3 overnight followed by adding 3 ml H2O2 
(30 %) to it. Samples were digested using microwave 
heated teflon bombs. Homogenized samples were diluted 
to a final volume of 25 ml and filtered through a 0.45 µm 
pore size syringe filter. Na+ and K+ concentrations in the 
solutions were measured with a PFP7 type flame 
photometer (Buck Scientific, Norwalk, USA). In order to 
eliminate eventual disturbances which ionization may 
cause, separate series of dilution were made to calibrate 
Na+ and K+ content. Every time, to the standard series of 
dilution the standard of the other alkali metal was added – 
in a concentration as the sample to be measured it required 
(Chen et al. 2005, Dipietro et al. 1988). 
 
Glycosaminoglycan disaccharide analysis 
We cut 0.5 g of skin, taken from the left scapula 
angulus inferior from rats into small slices and digested 
with 7.0 mg proteinase K (Sigma-Aldrich, Taufkirchen, 
Germany) in 10 ml 20 mM Tris-buffer (pH 7.0) at 55 °C 
for 16 h. The reaction was blocked by boiling the solution 
for 5 min. After centrifugation, we added 100 ml acetone 
to the supernatant and stored the tubes at -20 °C for 16 h. 
After precipitation, the tubes were centrifuged at 4,000 rpm 
for 5 min and the precipitate was dried at 90 °C overnight. 
After lyophilization, we dissolved the purified skin GAGs 
in 1.5 ml deionized water for HPLC analysis. We treated 
10 μl of samples with 7 mU of chondroitin ABC lyase 
(Sigma Aldrich, Taufkirchen, Germany) in 50 μl of 
100 mM Tris/150 mM sodium acetate buffer pH 8.0 at 
37 °C for 16 h. The reaction was blocked by boiling the 
solution for 1 min. We analyzed the unsaturated 
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disaccharides generated from hyaluronan (HA; ΔdiHA) 
and dermatan/chondroitin sulfate (DS/CS; Δdi4s and 
Δdi6s) after enzymatic treatment of the purified GAGs 
using HPLC-MS in selective ion mode according to 
previous literature data (Gill et al. 2012). HPLC analysis 
was performed by an Agilent 1260 Infinity LC system in 
conjunction with an Agilent 6460 triple-quadrupole mass 
spectrometer (Waldbroon, Germany). Chromatography 
was carried out using a porous graphitized carbon column 
(Hypercarb, Hypercarb Column, 5 μm, 100 mm × 4.6 mm) 
purchased from Thermo Scientific (Waltham, MA). For 
the separation gradient elution program was used: 
Solvent A was 0.1 % formic acid adjusted to pH 5.5 by 
ammonia and solvent B was solvent A in 90 % acetonitrile. 
The gradient used was 0-15 % B in 4 min and 15 % B over 
50 min. Standards of Hyaluronic acid (H9649-1MG) and 
Chondroitin-4,6-sulfate (CD004) were purchased from 
Sigma Aldrich (USA) and Iduron (Manchester, UK) 
respectively. 
 
Quantitative Real-Time PCR 
Total RNA was isolated from the skin tissue 
samples by Geneaid Total RNA Mini Kit (Geneaid, New 
Taipei, Taiwan), according to the manufacturer's 
instructions. 100 μg of total RNA was reverse-transcribed 
and VEGF-A and VEGF-C mRNA expressions were 
determined by real-time polymerase chain reaction (PCR) 
on LightCycler 480 (Roche Diagnostics, Mannheim, 
Germany). 
For quantitative PCR the following primer pairs 
were applied: VEGF-A forward: 5´-GTG CAC TGG 
ACC CTG GCT TTA C-3´; VEGF-A reverse: 5´-TTT 
TCT GGC TTT GTT CTA TCT TTC-3´; VEGF-C 
forward: 5´-TCC ACC ATC AAA CAT GCA GC-3´; 
VEGF-C reverse: 5´-TCA GTC GAT TTG TAC ATG 
GTC GT-3´; GAPDH forward: 5´-GGT GAA GGT CGG 
AGT CAA CG-3´; GAPDH reverse: 5´-CAA AGT TGT 
CAT GGA TGA CC-3´. 
The specificity of the PCR products was verified 
by the analysis of melting curves and by electrophoretic 
separation of the products on 2.5 % agarose gel followed 
by staining with ethidium bromide. The 2-∆∆CT value 
(relative fold change) was calculated. 
 
Results 
 
Skin sodium concentration and dietary NaCl intake 
Skin sodium content in each group reflected the 
levels of dietary sodium intake is shown in Figure 1. In 
Experiment 1 Na+ content of the skin in group HSD 
(1.334±0.022 mg/g; 116 %) showed an elevated level 
compared to group LSD (1.148±0.075 mg/g; 100 %; 
p=0.05), whereas group HSD/LSD showed an inter-
mediate value (1.192±0.051 mg/g; 104 %; p>0.05). The 
same tendencies were observed in Experiment 2: (LSD: 
0.974±0.069 mg/g; 100 % vs. HSD: 1.158±0.084 mg/g; 
118 %; p=0.0001). 
Since the homeostasis of Na+ and K+ are closely 
related, we investigated the K+ content of skin samples. 
The levels of skin K+ changed in the opposite direction 
compared to skin Na+: LSD 1.205±0.197 mg/g (100 %), 
HSD 1.001±0.155 mg/g (83 %), HSD/LSD 1.092± 
0.020 mg/g (90.5 %). Although the absolute amount of 
K+ showed differences between groups, intergroup 
comparison failed to reach significance: HSD vs. LSD 
p>0.05; HSD/LSD vs. HSD p>0.05). 
We obtained similar, although statistically not 
significant (p<0.07) result in Experiment 2: LSD: 
1.059±0.133 mg/g (100 %) vs. HSD 0.975±0.071 mg/g 
(92 %). Parallel with increased sodium intake, differences 
in sodium excreted in urine were detected in Experiment 1: 
LSD=97.6±62.78 mmol/l (100 %), HSD=172.75± 
32.15 mmol/l (172 %), HSD/LSD= 40.1±12.029 mmol/l 
(41 %); (HSD vs. LSD p>0.05; HSD vs. HSD/LSD 
p<0.001). In Experiment 2: HSD=69.0±29.8 mmol/l 
(100 %), LSD=21.3±7.5 mmol/l (30.86 %) (p<0.01). 
In order to rule out the possibility that  
Na+ overload in the skin is a consequence of kidney 
malfunction, we monitored the blood creatinine and urea 
levels at the end of each experiment. Since blood 
creatinine and urea levels as well as blood sodium levels 
in all experiments remained in the normal physiologic 
range for rats (creatinine: 20.5-40.6 µmol/ml; urea:  
4.5-8.96 µmol/ml; sodium 120-145 mmol/l) (data not 
shown) we concluded that the extremes in skin sodium 
content are the direct consequence of dietary 
manipulations. 
 
Excess Na+, K+ and water storage in the skin 
In Experiment 2 5.6 % difference in skin water 
content (m/m) between HSD and LSD was measured 
(HSD=60.4±4.043 % vs. LSD=54.79±4.055 %; 
p=0.0025). The difference between skin ion and water 
content holds important information about the level of 
osmotically inactive sodium storage. Therefore, from the 
Na+, K+, and water content of the skin  
a ([Na+ + K+]/water) quotient was calculated: 
 
[Na+] (mmol, dry skin) + [K+] (mmol, dry skin) / 
ml of water in wet skin 
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Fig. 1. Correlation graphs showing significant 
and strong correlation between skin Na+ and 
skin HA (A) and skin Na+ and skin CS (B) 
content in animals with different levels of 
dietary sodium intake (Experiment 1, n=6). 
The ([Na+ + K+]/water) quotient calculated from 
the respective data shows no significant difference between 
the two dietary groups: (LSD=0.126±0.001 mmol/ml vs. 
HSD=0.124±0.006 mmol/ml; p=0.51). 
The changes in the Na+ content of the skin were 
consistently counterbalanced by changes in skin  
K+ content leaving the ([Na+ + K+]/water) quotient 
between the two dietary groups unchanged. No difference 
was found in body weight between the two dietary groups 
in Experiment 2 (LSD 107.89 % vs. HSD 107.84 %, 
p=0.98). 
 
Relationship between skin Na+ and skin GAG levels 
Measurement of skin GAG content showed 
significant differences between dietary groups. 
Experiment 1: Hyaluronic acid: HSD=100 %, 
LSD=76.9 % (p<0.01), HSD/LSD=87.5 %; p<0.01; HSD 
vs. HSD/LSD p=0.096; Chondroitin-4,6-sulfate: 
HSD=100 %, LSD=82.7 % (p<0.01), HSD/LSD 87.4 % 
(p<0.053) (data expressed as means of groups; arbitrary 
units). 
The same tendencies were observed in 
Experiment 2: hyaluronic acid: HSD=100 %, 
LSD=64.5 % (p<0.0001); Chondroitin-4,6-sulfate: 
HSD=100 %, LSD=75.6 % (p<0.0001). We observed 
parallel changes in skin Na+ and GAG content: the levels 
of both GAGs raised in the high salt group, decreased in 
the low salt group, and showed an intermediate level in 
the group switched back from high salt to low salt diet.  
A coefficient, calculated from the respective data shows 
significant positive correlation between skin GAGs and 
skin Na+ content: Na+-hyaluronic acid (r=0.85, p=0.03); 
Na+-chondroitin-4,6-sulfate (r=0.82, p=0.046). 
 
Relationship of skin GAG content to VEGF-C and  
VEGF-A 
In Experiment 1 parallel with a 30 % increase in 
hyaluronic acid and 20 % in Chondroitin-4,6-sulfate 
content, mRNA levels of VEGF-C were also higher in 
group HSD (138.9 %) compared to group LSD (100 %) 
suggesting the GAG synthetizing role of VGF-C (HSD 
vs. LSD p=0.492). 
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Similar tendencies were observed in 
Experiment 2: Hyaluronic acid LSD=100 %, Hyaluronic 
acid HSD=152.9 %; (p<0.0001) Chondroitin-4,6-sulfate 
LSD=100 %, Chondroitin-4,6-sulfate HSD=132.2 % 
(p<0.0001); VEGF-C mRNA expressions LSD=100 %, 
HSD=151.2 % (p=0.07). Interestingly, no significant 
differences in the expression levels of VEGF-A were 
found in groups with different sodium intake. It slightly 
increased in both the LSD (HSD=100 %, LSD=112 %, 
p>0.05) and the HSD/LSD groups (122 %, p>0.05); HSD 
vs. HSD/LSD, p>0.05. 
Since changes in mRNA levels happen over  
a shorter time course it was reasonable to examine  
VEGF-A mRNA levels at an earlier time point (i.e. 72 h 
after the change in sodium intake). Similarly to 
Experiment 1, when comparing the VEGF-A mRNA 
levels of group HSD/LSD (in Experiment 3) to the 
mRNA level of group HSD (Experiment 2) no significant 
difference was observed (HSD 2=100 % vs. 
HSD/LSD 3=84 %; p=0.65). Changes in skin electrolyte 
and water content, skin GAG content and the mRNA 
expression levels of VEGF-A and VEGF-C in the 
experimental animals are summarized in Table 2. 
 
 
Table 2. Changes in skin electrolyte and water content, skin GAG content and the mRNA expression levels of VEGF-A and VEGF-C in 
animals receiving different levels of dietary sodium intake. 
 
 
LSD HSD HSD/LSD LSD HSD 
Experiment 1 Experiment 2 
Skin Na+ (mg/g) 1.148 ± 0.075 1.334 ± 0.022*# 1.192 ± 0.051 0.974 ± 0.069 1.158 ± 0.084* 
Skin K+ (mg/g) 1.205 ± 0.197 1.001 ± 0.155 1.092 ±0.020 1.059 ± 0.133 0.975 ± 0.071 
Skin water content 
(%) 
   54.799 ± 4.055 60.440 ± 4.043* 
[Na+ + K+] 
concentration in 
skin water (mmol/l) 
   0.126 ± 0.011 0.124 ± 0.006 
Skin HA 
content [AU] 
1,104,451 ± 170,395 1,435,126 ± 119,425* 1,256,268 ± 117,728 287,552 ± 57,567 187,598 ± 38,753* 
Skin CS 
content [AU] 
2,326,461 ± 165,196 2,787,854 ± 249,106* 2,459,153 ± 241661 500,518 ± 40,921 371,565 ± 55,539* 
Skin VEGF-A 
mRNA content [AU] 
1.123 ± 1.072 0.999 ± 1.008 1.224 ± 0.639 1.098 ± 0.577 0.879 ± 0.409 
Skin VEGF-C 
mRNA content [AU] 
0.720 ± 0.450 1.001 ± 0.421 0.850 ± 0.530 0.542 ± 0.381 0.820 ± 0.467 
Urine Na+ (mmol/l) 97.625 ± 62.781 172.75 ± 32.15# 40.125 ± 12.029 21.300 ± 7.500 69.000 ± 29.800* 
Body mass (%)    107.890 ± 5.950 107.840 ± 6.390 
MAP (Week 4) 
(mm Hg)    102 ± 19 98 ± 13 
 
LSD=low salt diet (4 weeks), HSD=high salt diet (4 weeks), HSD/LSD=high salt diet (4 weeks) followed by low salt diet (4 weeks). 
*=p<0.05 vs. LSD; #=p<0.05 vs. HSD/LSD. 
 
 
Discussion 
 
In the present study the impact of dietary sodium 
intake on the skin sodium and GAG content (Hyaluronic 
acid, Chondroitin sulfate), as well as on the expression of 
VEGF-A, VEGF-C mRNA was investigated in a rat 
model. Significant positive relationship was found 
between sodium intake, skin sodium and skin GAG 
content. Moreover, experimental evidences were 
provided for the involvement of VEGF-C in GAG 
metabolism, but no association was documented between 
VEGF-A and GAG. It is suggested that some of the 
excess sodium is bound to GAGs and stored in 
osmotically inactive form in the skin but the regulatory 
role of VEGFs in this process remained to be explored. 
Earlier studies have pointed out the Na+-binding 
ability of skin interstitial GAGs and the change in their 
amount followed by different levels of dietary sodium 
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intake. Sulyok and colleagues (Sulyok 2013) revealed 
that ECM-bound water consists of fractions (Ling 1992) 
with different mobility and composition (tightly bound, 
loosely bound and free), although they could not establish 
a clear relationship between GAG (hyaluronan) and 
bound water fraction. The pioneering experiments of 
Titze et al. (2002) on the hyperplasia of the lymph 
capillary network induced by dietary sodium overload 
explains the mechanism by which excess interstitial fluid 
is temporarily stored and drained back to the circulation 
(Marvar et al. 2009). 
Since the sodium and volume buffering capacity 
of this system is supposed to be limited, a regulating 
mechanism is essential in order to liberate excess 
interstitial fluid from GAGs and drain it back to the 
circulation for clearance by the kidney. 
Despite intensive research in this area, 
mechanism governing polymerization and 
depolymerization of GAGs is still elusive. For the 
phenomenon of regulated synthesis and degradation of 
GAGs, we found evidence in a 2013 issue of American 
Journal of Pathology. (Foster et al. 2013) and his research 
group provided evidences that the two isoforms of 
Vascular Endothelial Growth Factor, VEGF-A and 
VEGF-C influences the amount and charge density of the 
glycocalyx of conditionally immortalized glomerular 
endothelial cells of the kidney podocytes. In the kidney, 
these cells are constituents of the glomerular filtration 
barrier and are presumedly involved in the fine tuning of 
the filtering function of kidney podocytes. In their 
experimental setting, they proved that cultured cells can 
synthetize GAG molecules and are able to secrete them to 
the cell surface. They observed that VEGF-C 
significantly increased the negative charge density of the 
glycocalyx of GENC cells. VEGF-C was also able to 
intensify the production and secretion of negatively 
charged hyaluronic acid molecules. They also observed 
that VEGF-A does not affect the charge properties of 
negatively charged GAGs but instead promotes their 
detachment into the culture media. 
Our attempt in establishing causal relationship 
between sodium intake, skin GAG content and the two 
isoforms of VEGF has brought only partial success: GAG 
concentration in the skin showed strong and significant 
correlation with the amount of dietary Na+ intake. The 
decrease in GAG content after switch from high salt diet 
to low salt diet renders the regulated degradation of 
GAGs possible. The tendencies in the levels of VEGF-C 
also fits in this conception: increased VEGF-C levels are 
likely to reflect the organism’s need for extra sodium 
binding capacity. Although not reaching the desired level 
of significance, there is a tendency pointing toward the 
possible role of VEGF-C in the synthesis of skin 
interstitial GAGs. Selective blockade of VEGF-C in salt 
overloaded animals would give further evidence for the 
causal role of VEGF-C in GAG homeostasis. 
Based on the documented GAG-degrading effect 
(Foster et al. 2013) of VEGF-A, we expected elevated 
levels of VEGF-A in group HSD/LSD. Contrary to our 
expectations, no significant differences in the expression 
levels of VEGF-A were found in group HSD/LSD: 
HSD=100 %, LSD=112 %, HSD/LSD=122 % (HSD vs. 
LSD p>0.05; HSD vs. HSD/LSD p>0.05). Since changes 
in mRNA levels happen over a shorter time course it was 
reasonable to examine VEGF-A mRNA levels at  
an earlier time point (i.e. 72 h after the change in sodium 
intake). Similarly to Experiment 1, when comparing the 
VEGF-A mRNA levels of group HSD/LSD (in 
Experiment 3) to the mRNA level of group HSD 
(Experiment 2) no significant difference was observed 
(HSD 2=100 % vs. HSD/LSD 3=84 %; p=0.65) 
Having used normotensive, salt resistant Wistar 
rats, the lack of difference in blood pressure between 
HSD and LSD groups can be attributed to the properly 
functioning regulating mechanisms including the kidney 
the cardiovascular system and – presumably – the skin. 
However, since we did not block the regulating 
mechanism of the skin (unlike in the experiment of Titze 
et al. (2009)), the absence of the rise in blood pressure 
can only be considered as an indirect evidence of its role 
played in blood pressure regulation. 
As in our study the regulatory role of VEGFs in 
the control of GAGs-sodium interaction remained 
inconclusive further experiments are to be conducted to 
explore: a) the time course of the response pattern of 
VEGF-A/VEGF-C mRNA and protein expression to 
manipulation of sodium intake, b) the effect of  
anti-VEGF therapy to the sodium-GAG-VEGF interplay 
and c) the possible contribution of hormones/hormone-
like factors that are known to be involved in the synthesis 
and degradation of GAGs in various tissues needs also to 
be assessed. 
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